ARCHIVES

FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

Alan Rabson Outlasts Them All, Even His Bosses, As DCBD Chief

January 15, 1982

Colon Cancer Screening Interval 5-10 Years Suggested

September 26, 2008

Program Committee Lists 10 Papers At AACR Meeting

July 19, 1985

NCI Sends Letter To Grantees To Explain Tighter Funding.

March 16, 2001

FDA Approves Bexxar For Treatment Of Non-Hodgkin’s Lymphoma.

July 4, 2003

Two Avastin Trials Show OS Benefit In Advanced Disease

August 27, 2010